Thomas R. Dr Demeester

Thomas R. Dr Demeester's AcademicInfluence.com Rankings

Medical

#1006

World Rank

#1293

Historical Rank

Surgery

#66

World Rank

#97

Historical Rank

medical Degrees

Thomas R. Dr Demeester

Philosophy

#3502

World Rank

#5648

Historical Rank

Logic

#1197

World Rank

#1885

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Why Is Thomas R. Dr Demeester Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Thomas R. Dr Demeester's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Nissen Fundoplication for Gastroesophageal Reflux Disease: Evaluation of Primary Repair in 100 Consecutive Patients (1986) (810)
Patterns of Gastroesophageal Reflux in Health and Disease (1976) (694)
Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. (1974) (575)
Epigenetic patterns in the progression of esophageal adenocarcinoma. (2001) (542)
Laparoscopic Nissen Fundoplication Is an Effective Treatment for Gastroesophageal Reflux Disease (1994) (529)
Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. (1992) (520)
The Number of Lymph Nodes Removed Predicts Survival in Esophageal Cancer: An International Study on the Impact of Extent of Surgical Resection (2008) (519)
Laparoscopic repair of large type III hiatal hernia: objective followup reveals high recurrence rate. (2000) (516)
Technique, indications, and clinical use of 24 hour esophageal pH monitoring. (1980) (509)
Barrett's Esophagus: Comparison of Benign and Malignant Cases (1983) (507)
Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. (1993) (453)
Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. (1994) (427)
The lower esophageal sphincter in health and disease. (1988) (414)
Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. (2000) (380)
Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. (2000) (376)
Curative Resection for Esophageal Adenocarcinoma: Analysis Of 100 En Bloc Esophagectomies (2001) (373)
Development of the 24‐Hour Intraesophageal pH Monitoring Composite Scoring System (1986) (366)
Prevalence and risk factors for ischemia, leak, and stricture of esophageal anastomosis: gastric pull-up versus colon interposition. (2004) (358)
Esophageal eosinophilia with dysphagia (2005) (355)
Mesh complications after prosthetic reinforcement of hiatal closure: a 28-case series (2008) (349)
Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. (1997) (341)
Predicting Systemic Disease in Patients With Esophageal Cancer After Esophagectomy: A Multinational Study on the Significance of the Number of Involved Lymph Nodes (2008) (296)
The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication: prospective evaluation of 100 patients with "typical" symptoms. (1998) (288)
Is Barrett's metaplasia the source of adenocarcinomas of the cardia? (1994) (287)
DNA Methylation: An Alternative Pathway to Cancer (2001) (282)
Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. (2000) (281)
Mixed Reflux of Gastric and Duodenal Juices Is More Harmful to the Esophagus than Gastric Juice Alone: The Need for Surgical Therapy Re‐Emphasized (1995) (267)
Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux. (1992) (267)
Barrett's esophagus. Functional assessment, proposed pathogenesis, and surgical therapy. (1983) (257)
Indications, Surgical Technique, and Long‐Term Functional Results of Colon Interposition or Bypass (1988) (253)
Esophageal Function in Patients with Angina‐Type Chest Pain and Normal Coronary Angiograms (1982) (243)
Nissen Fundoplication for Gastroesophageal Reflux Disease (1988) (240)
Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication (1998) (237)
Normal 24-Hr ambulatory esophageal pH values (1992) (236)
Clinical and physiologic comparison of laparoscopic and open Nissen fundoplication. (1995) (233)
The Prevalence of Lymph Node Metastases in Patients With T1 Esophageal Adenocarcinoma: A Retrospective Review of Esophagectomy Specimens (2011) (223)
Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats. (1992) (222)
Long-Term Outcome of Antireflux Surgery in Patients With Barrett’s Esophagus (2001) (222)
Clinical value of quantitative ventilation-perfusion lung scans in the surgical management of bronchogenic carcinoma. (1980) (215)
High volume centers for esophagectomy: what is the number needed to achieve low postoperative mortality? (2004) (215)
Management of esophageal perforation. (1980) (212)
Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. (1995) (208)
Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids (2007) (208)
Preoperative diagnostic workup before antireflux surgery: an evidence and experience-based consensus of the Esophageal Diagnostic Advisory Panel. (2013) (205)
Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy. (1999) (200)
Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients. (2006) (197)
Absence of gastroesophageal reflux disease in a majority of patients taking acid suppression medications after Nissen fundoplication (2001) (196)
Intraoperative Assessment of Perfusion of the Gastric Graft and Correlation With Anastomotic Leaks After Esophagectomy (2015) (195)
Gastroesophageal reflux and pulmonary aspiration: incidence, functional abnormality, and results of surgical therapy. (1979) (194)
Alkaline gastroesophageal reflux: implications in the development of complications in Barrett's columnar-lined lower esophagus. (1989) (194)
Clinical and in vitro analysis of determinants of gastroesophageal competence. A study of the principles of antireflux surgery. (1979) (192)
Experimental and Clinical Results with Proximal End‐to‐End Duodenojejunostomy for Pathologic Duodenogastric Reflux (1987) (192)
Composition and concentration of bile acid reflux into the esophagus of patients with gastroesophageal reflux disease. (1997) (191)
Distribution and Significance of Epithelial Types in Columnar-Lined Esophagus (2001) (188)
Definition of histopathologic changes in gastroesophageal reflux disease. (2000) (183)
Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia. (1993) (182)
Telomerase reverse transcriptase expression is increased early in the Barrett’s metaplasia, dysplasia, adenocarcinoma sequence (2000) (178)
Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. (1999) (178)
Obesity and Gastroesophageal Reflux: Quantifying the Association Between Body Mass Index, Esophageal Acid Exposure, and Lower Esophageal Sphincter Status in a Large Series of Patients with Reflux Symptoms (2009) (176)
Esophageal epithelial response to gastroesophageal reflux (1978) (170)
Laparoscopic Sphincter Augmentation Device Eliminates Reflux Symptoms and Normalizes Esophageal Acid Exposure: One- and 2-Year Results of a Feasibility Trial (2010) (170)
Physiologic Basis for the Treatment of Epiphrenic Diverticulum (2002) (167)
A New Technique for Measurement of Pharyngeal pH: Normal Values and Discriminating pH Threshold (2009) (166)
Diagnosis and management of synchronous lung cancers. (1985) (163)
High Intraepithelial Eosinophil Counts in Esophageal Squamous Epithelium Are Not Specific for Eosinophilic Esophagitis in Adults (2008) (163)
Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinoma. (1994) (163)
The Duodenal Switch Operation for the Treatment of Morbid Obesity (2003) (163)
Omeprazole does not reduce gastroesophageal reflux: new insights using multichannel intraluminal impedance technology (2004) (162)
Histologic Classification of Patients Based on Mapping Biopsies of the Gastroesophageal Junction (2003) (158)
Chronic Respiratory Symptoms and Occult Gastroesophageal Reflux: A Prospective Clinical Study and Results of Surgical Therapy (1990) (158)
The extent of Barrett's esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure. (1999) (156)
The evaluation of objective measurements of gastroesophageal reflux and their contribution to patient management. (1976) (155)
Barrett's esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features. (2003) (154)
Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy. (1999) (154)
Risk factors and the prevalence of trocar site herniation after laparoscopic fundoplication (2001) (152)
Safety analysis of first 1000 patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease. (2015) (151)
A tailored approach to antireflux surgery. (1995) (149)
Alkaline gastroesophageal reflux. (1978) (149)
Vagal-Sparing Esophagectomy: The Ideal Operation for Intramucosal Adenocarcinoma and Barrett with High-Grade Dysplasia (2007) (146)
Recurrence after esophagectomy for adenocarcinoma: defining optimal follow-up intervals and testing. (2010) (144)
Vagal-Sparing Esophagectomy: A More Physiologic Alternative (2002) (142)
The LINX® reflux management system: confirmed safety and efficacy now at 4 years (2012) (140)
Magnetic Augmentation of the Lower Esophageal Sphincter: Results of a Feasibility Clinical Trial (2008) (140)
A Multicenter Study of Survival After Neoadjuvant Radiotherapy/Chemotherapy and Esophagectomy for ypT0N0M0R0 Esophageal Cancer (2010) (139)
Specificity and sensitivity of objective diagnosis of gastroesophageal reflux disease. (1987) (135)
Functional foregut abnormalities in Barrett's esophagus. (1993) (133)
Hiatal Hernia, Lower Esophageal Sphincter Incompetence, and Effectiveness of Nissen Fundoplication in the Spectrum of Gastroesophageal Reflux Disease (2009) (131)
Length of the distal esophageal sphincter and competency of the cardia. (1986) (130)
Does duodenal juice reflux into the esophagus of patients with complicated GERD? Evaluation of a fiberoptic sensor for bilirubin. (1995) (126)
Laparoscopic versus open repair of paraesophageal hernia: the second decade. (2011) (126)
Short esophagus: analysis of predictors and clinical implications. (1999) (123)
Gastric juice protects against the development of esophageal adenocarcinoma in the rat. (1996) (123)
Alkaline gastroesophageal reflux: assessment by ambulatory esophageal aspiration and pH monitoring. (1994) (122)
Interaction of lower esophageal sphincter pressure and length of sphincter in the abdomen as determinants of gastroesophageal competence. (1982) (120)
A proposal for a new validated histological definition of the gastroesophageal junction. (2006) (119)
Greenfield filter versus Mobin-Uddin umbrella: the continuing quest for the ideal method of vena caval interruption. (1980) (118)
Role of the lower esophageal sphincter and hiatal hernia in the pathogenesis of gastroesophageal reflux disease (1999) (117)
Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma. (2011) (115)
Elevated body mass disrupts the barrier to gastroesophageal reflux; discussion 1018-9. (2001) (112)
Duodenoesophageal reflux induces esophageal adenocarcinoma without exogenous carcinogen (1998) (110)
Ambulatory 24-hour Esophageal pH Monitoring (2003) (109)
The impact of an antireflux procedure on intestinal metaplasia of the cardia. (1998) (108)
Potentially curable cancer of the esophagus. (1982) (106)
En bloc vs transhiatal esophagectomy for stage T3 N1 adenocarcinoma of the distal esophagus. (2004) (106)
Three-dimensional pressure image and muscular structure of the human lower esophageal sphincter. (1995) (106)
Predictive factors of Barrett esophagus: multivariate analysis of 502 patients with gastroesophageal reflux disease. (2001) (105)
Ambulatory 24-hour Esophageal pH Monitoring: Why, When, and What to Do (2003) (105)
Three-dimensional imaging of the lower esophageal sphincter in gastroesophageal reflux disease. (1991) (104)
Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus (2002) (104)
Living-related donor lobectomy for bilateral lobar transplantation in patients with cystic fibrosis. (1994) (104)
Columnar-Lined Esophagus Without Intestinal Metaplasia Has No Proven Risk of Adenocarcinoma (2012) (101)
Biology of gastroesophageal reflux disease: pathophysiology relating to medical and surgical treatment. (1999) (101)
Use of a magnetic sphincter for the treatment of GERD: a feasibility study. (2008) (100)
Circadian esophageal motor function in patients with gastroesophageal reflux disease. (1990) (99)
Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus. (2006) (98)
Bravo catheter-free pH monitoring: normal values, concordance, optimal diagnostic thresholds, and accuracy. (2009) (97)
Barrett's esophagus. The significance of p53 in clinical practice. (1997) (96)
Does delayed gastric emptying contribute to gastroesophageal reflux disease? (1989) (94)
Selective therapeutic approach to cancer of the lower esophagus and cardia. (1988) (93)
Adenocarcinomas of the Distal Esophagus and “Gastric Cardia” Are Predominantly Esophageal Carcinomas (2007) (93)
Gastroesophageal Reflux in Achalasia (When Is Reflux Really Reflux?) (1997) (92)
Effect of paraesophageal hernia on sphincter function and its implication on surgical therapy. (1984) (92)
Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal esophagus. (2009) (91)
Can the combination of symptoms and endoscopy confirm the presence of gastroesophageal reflux disease? (1997) (91)
The Mutagenic Potential of Duodenoesophageal Reflux (2005) (90)
Management of tumor adherent to the vertebral column. (1989) (89)
Value of physiologic assessment of foregut symptoms in a surgical practice. (1993) (89)
Surgery and the management of peripheral lung tumors adherent to the parietal pleura. (1992) (89)
Concentration of refluxed acid and esophageal mucosal injury. (1992) (86)
The impact of a dedicated trauma program on outcome in severely injured patients. (1995) (85)
Outcome of respiratory symptoms after antireflux surgery on patients with gastroesophageal reflux disease. (1996) (85)
Esophageal resection with colon interposition for end-stage achalasia. (1995) (85)
Is intestinal metaplasia a necessary precursor lesion for adenocarcinomas of the distal esophagus, gastroesophageal junction and gastric cardia? (2007) (85)
Relationship of a Satisfactory Outcome to Normalization of Delayed Gastric Emptying After Nissen Fundoplication (1989) (84)
En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma. (2008) (84)
Relationship of a hiatal hernia to the function of the body of the esophagus and the gastroesophageal junction. (1981) (82)
Effect of Nissen fundoplication on esophageal motor function. (1992) (81)
Acute pancreatitis with hyperlipemia. (1971) (81)
Evaluation of the Nissen antireflux procedure by esophageal manometry and twenty-four hour pH monitoring. (1975) (80)
Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma. (2005) (79)
Predictive factors of coexisting cancer in Barrett’s high-grade dysplasia (2006) (78)
Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus. (2003) (77)
Cardiac mucosa in the remnant esophagus after esophagectomy is an acquired epithelium with Barrett's-like features. (2004) (77)
Evaluation of elevation of the head of the bed, bethanechol, and antacid foam tablets on gastroesophageal reflux (1981) (76)
Pharyngoesophageal dysfunctions. The role of cricopharyngeal myotomy. (1985) (76)
Esophageal function in patients with reflux-induced strictures and its relevance to surgical treatment. (1989) (76)
The pattern of esophageal acid exposure in gastroesophageal reflux disease influences the severity of the disease. (1999) (76)
Gastric electrical stimulation: an alternative surgical therapy for patients with gastroparesis. (2005) (75)
Computerized identification of pathologic duodenogastric reflux using 24-hour gastric pH monitoring. (1991) (72)
Midgut nonrotation in adults. An aggressive approach. (1975) (72)
Endoscopic grading of the gastroesophageal valve in patients with symptoms of gastroesophageal reflux disease (GERD) (1999) (71)
Clinical significance of p53 mutations in adenocarcinoma of the esophagus and cardia. (2000) (71)
The Histologic Squamo-oxyntic Gap: An Accurate and Reproducible Diagnostic Marker of Gastroesophageal Reflux Disease (2010) (70)
Management of gastric emptying disorders following the Roux-en-Y procedure. (1988) (70)
Surgical treatment of Barrett's carcinoma (1994) (69)
Effect of gastroduodenal juice and dietary fat on the development of barrett's esophagus and esophageal neoplasia: An experimental rat model (1994) (68)
The Impact of Gastric Distension on the Lower Esophageal Sphincter and Its Exposure to Acid Gastric Juice (2010) (67)
Selection of patients for curative or palliative resection of esophageal cancer based on preoperative endoscopic ultrasonography. (1994) (67)
The role of fundoplication in the treatment of type II paraesophageal hernia. (1996) (67)
Preoperative lower esophageal sphincter pressure affects outcome of laparoscopic esophageal myotomy for achalasia (2004) (66)
Arterial anatomic considerations in colon interposition for esophageal replacement. (1995) (66)
Gastroesophageal reflux disease and mucosal injury with emphasis on short-segment Barrett’s esophagus and duodenogastroesophageal reflux (1998) (66)
Endoscopic signs for gastroesophageal reflux objectively evaluated. (1976) (66)
Nissen fundoplication prevents shortening of the sphincter during gastric distention. (1997) (65)
The diagnosis and management of Barrett's esophagus. (1999) (65)
Cdx-2 expression in squamous and metaplastic columnar epithelia of the esophagus. (2006) (64)
Esophageal carcinoma with respiratory tract fistula (1984) (64)
LINX® Reflux Management System in chronic gastroesophageal reflux: a novel effective technology for restoring the natural barrier to reflux (2013) (64)
Reduction of interleukin 8 gene expression in reflux esophagitis and Barrett's esophagus with antireflux surgery. (2007) (63)
The role of gallium-67 scanning in the clinical staging and preoperative evaluation of patients with carcinoma of the lung. (1979) (62)
Esophageal Disorders: Pathophysiology and Therapy (1985) (61)
Gallium-67 scanning for carcinoma of the lung. (1976) (60)
Duodenogastric reflux and reflux esophagitis. (1984) (59)
Gastroesophageal reflux disease in asthma: effects of medical and surgical antireflux therapy on asthma control. (2000) (59)
Helicobacter pylori is not associated with the manifestations of gastroesophageal reflux disease. (1999) (59)
Minimizing the side effects of antireflux surgery (1992) (59)
Determinants of intestinal metaplasia within the columnar-lined esophagus. (2000) (58)
Indications, technique, and clinical use of ambulatory 24-hour esophageal motility monitoring in a surgical practice. (1993) (58)
Alimentary satisfaction, gastrointestinal symptoms, and quality of life 10 or more years after esophagectomy with gastric pull-up. (2014) (58)
The benefits of open lung biopsy in patients with previous non-diagnostic transbronchial lung biopsy. A guide to appropriate therapy. (1980) (57)
Physiologic mechanism and preoperative prediction of new-onset dysphagia after laparoscopic Nissen fundoplication (2002) (56)
The Dilated Distal Esophagus: A New Entity That Is the Pathologic Basis of Early Gastroesophageal Reflux Disease (2011) (56)
Pharyngeal swallowing. The major factor in clearance of esophageal reflux episodes. (1993) (56)
Duodenogastric reflux potentiates the injurious effects of gastroesophageal reflux (2006) (55)
Operation for diagnosis and treatment of pericardial effusions. (1984) (55)
Functional Evaluation of the Interposed Colon as an Esophageal Substitute (1976) (55)
The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma. (2004) (54)
Clinical value of endoscopy and histology in the diagnosis of duodenogastric reflux disease. (1992) (54)
Barrett's Esophagus in Females: A Comparative Analysis of Risk Factors in Females and Males (2005) (52)
The effect of symptoms and nonspecific motility abnormalities on outcomes of surgical therapy for gastroesophageal reflux disease. (1994) (52)
The impact of reflux composition on mucosal injury and esophageal function (2006) (52)
The safety and usefulness of endoscopy for evaluation of the graft and anastomosis early after esophagectomy and reconstruction (2005) (52)
Treatment of advanced gastroesophageal reflux disease with Collis gastroplasty and Belsey partial fundoplication. (1998) (50)
Modified stage I (T1N0M0, T2N0M0), nonsmall cell lung cancer: treatment results, recurrence patterns, and adjuvant immunotherapy. (1986) (50)
Long-term quality of life and alimentary satisfaction after esophagectomy with colon interposition. (2014) (50)
A new technique to define and clarify esophageal motor disorders. (1990) (50)
Esophageal carcinoma: current controversies. (1997) (50)
Surgery for esophageal motor disorders. (1982) (50)
Outpatient physiologic testing and surgical management of foregut motility disorders. (1992) (49)
Esophageal replacement for end-stage benign esophageal disease. (1998) (49)
Response of the lower esophageal sphincter to gastric distention by carbonated beverages (2006) (49)
The distal esophageal sphincter and its relationship to gastroesophageal reflux. (1974) (49)
Esophageal Adenocarcinoma in Patients ≤50 Years Old: Delayed Diagnosis and Advanced Disease at Presentation (2004) (49)
Cystic and bullous lung disease. (1991) (48)
The role of the esophageal body in the antireflux mechanism. (1982) (48)
Long-term Follow-up After Anti-reflux Surgery in Patients with Barrett’s Esophagus (2010) (48)
N-acetylcysteine: its bioavailability and interaction with ifosfamide metabolites. (1983) (47)
Esophageal replacement for end-stage benign esophageal disease. (1997) (47)
Glutathione S-transferase-Pi expression is downregulated in patients with Barrett’s esophagus and esophageal adenocarcinoma (2002) (46)
Ambulatory 24-hour esophageal manometry in the evaluation of esophageal motor disorders and noncardiac chest pain. (1991) (46)
Laparoscopic Wedge Fundectomy for Collis Gastroplasty Creation in Patients With a Foreshortened Esophagus (2014) (45)
Respiratory Insufficiency Secondary to Acute Pancreatitis (1972) (45)
Genetic Variations in Angiogenesis Pathway Genes Predict Tumor Recurrence in Localized Adenocarcinoma of the Esophagus (2010) (45)
Prospective randomized evaluation of intrathoracic intercostal nerve block with bupivacaine on postoperative ventilatory function. (1979) (45)
Response of the Interposed Human Colonic Segment to an Acid Challenge (1973) (45)
Nonobstructive dysphagia in gastroesophageal reflux disease: a study with combined ambulatory pH and motility monitoring. (1992) (45)
Surgical therapy for Barrett's esophagus: prevention, protection and excision. (2002) (44)
A new intraluminal antigastroesophageal reflux procedure in baboons. (1997) (44)
Esophagectomy for cancer in octogenarians. (2010) (44)
Perforation of the esophagus. (1986) (43)
Outcome effect of adherence to operative principles of Nissen fundoplication by multiple surgeons. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. (1993) (43)
Abnormal Esophageal Body Function: Radiographic-Manometric Correlation (1999) (42)
Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma. (1976) (42)
Quantitative, tissue-specific analysis of cyclooxygenase gene expression in the pathogenesis of Barrett’s adenocarcinoma (2004) (41)
Technique and experience with 24-hour esophageal pH monitoring in children. (1977) (41)
Local recurrence of resectable non‐oat cell carcinoma of the lung: A warning against conservative treatment for N0 and N1 disease (1986) (40)
Physiologic assessment and surgical management of diffuse esophageal spasm. (1992) (40)
Pathologic duodenogastric reflux associated with persistence of symptoms after cholecystectomy. (1995) (40)
Gastric pathology as an initiator and potentiator of gastroesophageal reflux disease. (1997) (40)
Thoraco-Abdominal Pressure Gradients During the Phases of Respiration Contribute to Gastroesophageal Reflux Disease (2011) (40)
Increased c-myb mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma. (2001) (39)
Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP). (1978) (39)
Surgery and current management for cancer of the esophagus and cardia: Part II. (1988) (39)
Surgical Management of Submucosal Esophageal Cancer: Extended or Regional Lymphadenectomy? (2010) (37)
Body Mass Index is Associated with Barrett Esophagus and Cardiac Mucosal Metaplasia (2006) (37)
Insights Gained from Symptom Evaluation of Esophageal Motility Disorders: A Review of 4,215 Patients (2012) (37)
Effect of duodenal components of the refluxate on development of esophageal neoplasia in rats (1998) (37)
LINX™ Reflux Management System: magnetic sphincter augmentation in the treatment of gastroesophageal reflux disease (2012) (36)
The Value of High-Resolution Manometry in the Assessment of the Resting Characteristics of the Lower Esophageal Sphincter (2009) (36)
Minimally Invasive Surgery of the Foregut (1995) (35)
Antireflux Surgery Normalizes Cyclooxygenase-2 Expression in Squamous Epithelium of the Distal Esophagus (2006) (35)
A simplified technique for intrathoracic stomach repair: laparoscopic fundoplication with Vicryl mesh and BioGlue crural reinforcement (2010) (35)
Excellent quality of life after Nissen fundoplication depends on successful elimination of reflux symptoms and not the invasiveness of the surgical approach. (2002) (35)
Preoperative evaluation with differential pulmonary function. (1974) (35)
Increased acid exposure in patients with gastroesophageal reflux disease influences cyclooxygenase-2 gene expression in the squamous epithelium of the lower esophagus. (2004) (35)
Intraluminal pH and Goblet Cell Density in Barrett’s Esophagus (2012) (35)
Surgical management of hypertensive lower esophageal sphincter with dysphagia or chest pain (2003) (35)
The Cause of Dysphagia in Uncomplicated Sliding Hiatal Hernia and its Relief by Hiatal Herniorrhaphy: A Roentgenographic, Manometric, and Clinical Study (1990) (34)
Ultrasonic epithelial ablation of the lower esophagus without stricture formation (1998) (34)
Indications, benefits and outcome of laparoscopic Nissen fundoplication. (1996) (34)
Abnormal plasma gut hormones in pathologic duodenogastric reflux and their response to surgery. (1992) (34)
Chronology of the Barrett's metaplasia-dysplasia-carcinoma sequence. (2004) (33)
A safe and noninvasive test for vagal integrity revisited. (2002) (33)
The hypertensive lower esophageal sphincter: A motility disorder with manometric features of outflow obstruction (2003) (33)
Twenty-four-hour gastric luminal pH in normal subjects: influence of probe position, food, posture, and duodenogastric reflux. (1994) (32)
Detection of gastric conduit ischemia or anastomotic breakdown after cervical esophagogastrostomy: the use of computed tomography scan versus early endoscopy (2010) (32)
THE EFFECT OF HETEROLOGOUS ANTI-LYMPHOCYTE SERUM ON MOUSE HEMOPOIETIC STEM CELLS (1968) (32)
Metabolism of carcinogenic nitrosamines in the rat and human esophagus and induction of esophageal adenocarcinoma in rats. (1993) (32)
Etiology of intestinal metaplasia at the gastroesophageal junction (2002) (32)
Survivin, a potential biomarker in the development of Barrett's adenocarcinoma. (2005) (31)
Gland ducts and multilayered epithelium in mucosal biopsies from gastroesophageal-junction region are useful in characterizing esophageal location. (2005) (31)
Mechanical effect of the Angelchik prosthesis on the competency of the gastric cardia: pathophysiologic implications and surgical perspectives. (1997) (31)
Postprandial gastroesophageal reflux in normal volunteers and symptomatic patients (1998) (31)
Plasma DNA as a molecular marker for completeness of resection and recurrent disease in patients with esophageal cancer. (2007) (31)
Factors Influencing the Transit of a Gelatin Capsule in the Esophagus (1987) (31)
Measurement of gastric pH in ambulatory esophageal pH monitoring (2009) (31)
Prognostic factors in patients with non‐small cell bronchogenic carcinoma and brain metastases (1982) (31)
Plasma DNA is more reliable than carcinoembryonic antigen for diagnosis of recurrent esophageal cancer. (2008) (31)
Clinical use of 24-hour gastric pH monitoring vs o-diisopropyl iminodiacetic acid (DISIDA) scanning in the diagnosis of pathologic duodenogastric reflux. (1990) (31)
Outcome after laparoscopic fundoplication is not dependent on a structurally defective lower esophageal sphincter (1998) (30)
Motility in the Hunt-Lawrence pouch after total gastrectomy. (1994) (30)
Role of esophageal body function in gastroesophageal reflux disease: implications for surgical management. (1997) (30)
Retinoic acid receptor-α messenger RNA expression is increased and retinoic acid receptor-γ expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence (2001) (30)
Upregulation of ornithine decarboxylase mrna expression in barrett’s esophagus and barrett’s-associated adenocarcinoma (2001) (30)
Phase I trial of an implanted battery-powered, programmable drug delivery system for continuous doxorubicin administration. (1985) (30)
Short-segment Barrett’s esophagus: A prevalent complication of gastroensophageal reflux disease with malignant potential (1997) (30)
Molecular determinants in targeted therapy for esophageal adenocarcinoma. (2006) (29)
Are the motility abnormalities of achalasia reversible? An experimental outflow obstruction in the feline model. (1999) (29)
The significance of the gastric secretory state in gastroesophageal reflux disease. (1989) (29)
Vagal-sparing esophagectomy. (2008) (29)
Redefining gastroesophageal reflux (GER) (2003) (29)
Esophagectomy for unsuccessful antireflux operations. (1998) (29)
Clinical biology of the Barrett's metaplasia, dysplasia to carcinoma sequence. (2001) (29)
Local nerve block anesthesia for peroral endoscopy. (1977) (28)
Is adenocarcinoma following esophagoduodenostomy without carcinogen in the rat reflux-induced? (2000) (28)
Association of Adenocarcinomas of the Distal Esophagus, “Gastroesophageal Junction,” and “Gastric Cardia” With Gastric Pathology (2010) (27)
Surgical exposure of the upper abdominal aorta and its branches. (1971) (27)
An intraluminal surgical approach to the management of gastric bezoars (1995) (27)
Increasing cyclooxygenase‐2 (cox‐2) gene expression in the progression of Barrett's esophagus to adenocarcinoma correlates with that of Bcl‐2 (2006) (27)
Effect of Barrett's esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma. (2013) (27)
Comparison of the clinical and histological characteristics and survival of distal esophageal-gastroesophageal junction adenocarcinoma in patients with and without barrett mucosa. (2005) (26)
Dysplasia in Barrett's esophagus: diagnosis, surveillance and treatment. (1996) (26)
Laparoscopic Nissen fundoplication assessment: task analysis as a model for the development of a procedural checklist (2009) (26)
Intra-abdominal pressure and manometric data of the distal esophageal sphincter. Their relationship to gastroesophageal reflux. (1980) (26)
Carcinoembryonic antigen measurements in the management of esophageal cancer: an indicator of subclinical recurrence. (1995) (26)
The mode of Roux-en-Y reconstruction affects motility in the efferent limb. (1996) (26)
The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non-small cell lung cancer (1986) (25)
Technique, indications, and clinical use of ambulatory 24-hour gastric pH monitoring in a surgical practice. (1994) (25)
Pharyngeal swallowing disorders: selection for and outcome after myotomy. (1998) (25)
Analysis of thirty-two patients with Schatzki's ring. (1989) (25)
Talc pleurodesis: talc slurry versus thoracoscopic talc insufflation in a porcine model. (1996) (24)
Immunosuppression in patients with Barrett's esophagus. (1992) (24)
A contemporaneous comparison of hospital charges for laparoscopic and open Nissen fundoplication (1995) (23)
Importance of duodenogastric reflux in the surgical outpatient practice. (1999) (22)
Proximal esophageal pH monitoring: improved definition of normal values and determination of a composite pH score. (2010) (22)
Rat Reflux Model of Esophageal Cancer and Its Implication in Human Disease (2015) (22)
Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach. (1983) (22)
Predictors of staging accuracy, pathologic nodal involvement, and overall survival for cT2N0 carcinoma of the esophagus (2019) (22)
Reflux and motility pattern in Barrett’s esophagus (1992) (22)
Surgical treatment of dysplasia and adenocarcinoma. (1997) (22)
Survival in lymph node negative adenocarcinoma of the esophagus after R0 resection with and without neoadjuvant therapy: evidence for downstaging of N status. (2009) (21)
Validation of a rodent model of Barrett’s esophagus using quantitative gene expression profiling (2009) (21)
Isolated upright gastroesophageal reflux is not a contraindication for antireflux surgery. (1997) (21)
Home self-dilatation for esophageal strictures. (2014) (21)
Retinoic acid receptor-alpha messenger RNA expression is increased and retinoic acid receptor-gamma expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence. (2001) (21)
Who benefits from antireflux surgery? (1992) (21)
Small‐cell carcinoma of the lung: A five‐year experience with combined modality therapy (1980) (21)
Indications, Principles of Procedure Selection, and Technique of Laparoscopic Nissen Fundoplication (1995) (21)
Etiology and importance of alkaline esophageal reflux. (1991) (20)
Sequential staging in bronchogenic carcinoma. (1979) (20)
Adenocarcinoma of the Esophagus in the Young (2013) (20)
Barrett's esophagus. Update of pathophysiology and management. (1998) (20)
Delayed esophagogastrostomy: a safe strategy for management of patients with ischemic gastric conduit at time of esophagectomy. (2009) (20)
Barrett's esophagus. (2001) (20)
Surgery and current management for cancer of the esophagus and cardia. (1988) (20)
Proposed approach to the challenging management of progressive gastroesophageal reflux disease (2018) (20)
'Efficacy' of esophageal peristalsis: a manometric parameter to quantify esophageal body dysfunction. (2004) (20)
Clinical evaluation of the BRAVOTM probe-a catheter-free ambulatory esophageal pH monitoring system (2001) (19)
Editorial comment: The short esophagus: going, going, gone? (2003) (19)
Permanent extracorporeal esophagogastric tube for esophageal replacement. (1976) (19)
The state of surgical treatment of gastroesophageal reflux disease after five decades. (2014) (19)
Three-dimensional manometric imaging of the lower esophageal sphincter. (1995) (19)
Benefits of Open Lung Biopsy in Patients with Previous Nondiagnostic Transbronchial Lung Biopsy (1980) (19)
Intraoperative maintenance of tissue perfusion prevents ARDS. Adult Respiratory Distress Syndrome. (1996) (18)
Fibrovascular polyp of the esophagus requiring esophagectomy. (2007) (18)
The relationship between gastric pH and the emptying of solid, semisolid and liquid meals (1993) (18)
Endoscopic treatment of Zenker's diverticulum. (1999) (18)
Response of the distal esophageal sphincter to respiratory and positional maneuvers in humans. (1976) (18)
A selective therapeutic approach to gastric cancer in a large public hospital. (1995) (18)
Benign esophageal disease (1987) (18)
Day-to-day discrepancy in Bravo pH monitoring is related to the degree of deterioration of the lower esophageal sphincter and severity of reflux disease (2011) (18)
Polypoid sarcomas of the esophagus. A rare but potentially curable neoplasm. (1975) (18)
The Angelchik prosthesis: what have we learned in fifteen years? (1994) (18)
Use and prognostic value of staging mediastinoscopy in non-small-cell lung cancer. (1987) (17)
An Improved Method of Assessing Esophageal Emptying Using the Timed Barium Study Following Surgical Myotomy for Achalasia (2008) (17)
Prospective Randomized Evaluation of Intrathoracic Intercostal Nerve Block with Bupivacaine on Postoperative Ventilatory Function (1982) (17)
Surgical management of cutaneous lye burns. (1970) (16)
Effect of alprazolam (Xanax) on esophageal motility and acid reflux. (1992) (16)
The colon as an esophageal substitute (1995) (16)
Manometry of the Lower Esophageal Sphincter: Inter- and Intraindividual Variability of Slow Motorized Pull-Through Versus Station Pull-Through Manometry (2003) (16)
Malignant mesothelioma: A metastasis to the face (1980) (16)
Clinical Significance of Esophageal Outflow Resistance Imposed by a Nissen Fundoplication. (2019) (16)
Local recurrence of resectable non-oat cell carcinoma of the lung. A warning against conservative treatment for N0 and N1 disease. (1986) (16)
Guided biopsies of abnormalities on nuclear bone scans. Technique and indications. (1983) (16)
Foregut motor disorders and their surgical management. (1981) (15)
The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non-small cell lung cancer. (1986) (15)
Emerging Concepts for the Endoscopic Management of Superficial Esophageal Adenocarcinoma (2016) (15)
Normal esophageal body function: a study using ambulatory esophageal manometry. (1998) (15)
Evaluation of brush cytology as an independent technique for detection of esophageal carcinoma. (1985) (15)
Combined modality therapy for stage III(MO) non-oat cell bronchogenic carcinoma (1978) (15)
Abnormal gastric emptying in patients with gastroesophageal reflux. (1977) (15)
Etiology and Natural History of Gastroesophageal Reflux Disease and Predictors of Progressive Disease (2019) (15)
Pleural Involvement in Stage IIIMO Non‐Small‐Cell Bronchogenic Carcinoma A Need to Differentiate Subtypes (1986) (15)
Controversies in the current therapy of carcinoma of the esophagus. (2002) (15)
Effect of duodenal switch procedure on gastric acid production, intragastric pH, gastric emptying, and gastrointestinal hormones. (1992) (15)
Combined gastric and esophageal 24-hour pH monitoring in patients with gastroesophageal reflux. (1979) (15)
Bravo capsule induction of esophageal hypercontractility and chest pain (2006) (15)
Influence of Dissolution Rate and pH of Oral Medications on Drug-Induced Esophageal Injury (1990) (14)
Circular stapled pyloroplasty: a fast and effective technique for pyloric disruption during esophagectomy with gastric pull-up. (2011) (14)
Foreign body entrapment in the esophagus of healthy subjects—A manometric and scintigraphic study (2006) (14)
Repair of a through-and-through gunshot wound of the aortic arch using a heparinized shunt. (1973) (14)
Gastroesophageal reflux: the use of pH monitoring. (1995) (14)
Small-cell carcinoma of the lung: the prognostic significance of stage on survival. (1979) (14)
Evaluation of the intestinal microflora in the rat model for esophageal adenocarcinoma. (2000) (13)
The gene expression profile of cardia intestinal metaplasia is similar to that of Barrett's esophagus, not gastric intestinal metaplasia. (2011) (13)
Elevated serum gastrin levels in patients with gastric cancer (1991) (13)
Mode of action of antilymphocyte serum. (1969) (13)
Loss of Alkalization in Proximal Esophagus: a New Diagnostic Paradigm for Patients with Laryngopharyngeal Reflux (2010) (13)
Camp chemotherapy for metastatic non‐oat cell bronchogenic carcinoma. A 7‐year experience (1975–1981) with 160 patients (1985) (13)
LINX TM Reflux Management System : magnetic sphincter augmentation in the treatment of gastroesophageal reflux disease (2012) (13)
Manual verification of computer analysis of 24-hour esophageal motility. (1993) (13)
The physiologic mechanism and preoperative prediction of new onset dysphagia after laparoscopic Nissen fundoplication (2001) (12)
Twenty-four-hour pH monitoring of esophageal function. Its use in evaluation in symptomatic patients after truncal vagotomy and gastric resection or drainage. (1981) (12)
Endobronchial adenoid cystic carcinoma. (1991) (12)
Evaluation of 48 hr PH monitoring with the BRAVO probe, a catheter-free system, in 38 asymptomatic healthy volunteers (2003) (12)
The Crura and Crura-Sphincter Pressure Dynamics in Patients with Isolated Upright and Isolated Supine Reflux (2001) (12)
Staging of esophageal carcinoma. (2003) (12)
Esophageal bolus transport measured by simultaneous muttichannel intraluminal impedance and manofluorometry (2001) (11)
Metastatic non-small cell bronchogenic carcinoma: a randomized trial of sequential vs combination chemotherapy. (1981) (11)
Carcinogenesis in reflux disease—In search for bile‐specific effects (2007) (11)
NISSEN FUNDOPLICATION FOR GASTROESOPHAGEAL REFLUX DISEASE: The ‘DeMeester’ modification – technique and results (1996) (11)
Does Toupet fundoplication out-perform the Nissen procedure as the operation of choice for gastro-esophageal reflux disease? (1994) (11)
Complete and partial laparoscopic fundoplication for gastroesophageal reflux disease (1997) (11)
Prognostic significance of immunological tests in lung cancer. (1981) (11)
The current management of gastroesophageal reflux. (1991) (11)
Clinicopathologic correlations demonstrating the failure of 67gallium scanning in determining response to radiotherapy. (1978) (10)
Dysplastic Barrett's: is continued surveillance appropriate? (1994) (10)
Surgery and current management for cancer of the esophagus and cardia: Part I. (1988) (10)
DIFFERENTIAL COUNTS AND SURVIVAL IN LUNG CANCER (1978) (10)
The use of serum albumin for further classification of Stage III non-oat cell lung cancer and its therapeutic implications. (1984) (10)
Gastro-esophageal reflux disease confined to the sphincter. (2001) (10)
Static and dynamic function of the lower esophageal sphincter before and after laparoscopic nissen fundoplication (1997) (10)
Gastroduodenal function in Barrett's esophagus. (1995) (10)
Normal Esophageal Body Function: A Study Using Ambulatory Esophageal Manometry (1998) (10)
TELOMERASE REVERSE TRANSCRIPTASE EXPRESSION IS INCREASED EARLY IN BARRETTE’S METAPLASIA, DYSPLASIA, CARCINOMA SEQUENCE (2000) (9)
Selective cricopharyngeal myotomy for Zenker's diverticulum. (2003) (9)
The relationship between immune reactivity, serum cortisol, and stage of disease in patients with non-oat-cell bronchogenic carcinoma. (1979) (9)
Coronary Artery Disease in Aortic Stenosis: Importance of Coronary Arteriography and Surgical Implications (1983) (9)
Antireflux surgery in the management of Barrett’s esophagus (2000) (9)
Bronchogenic carcinoma located in the aortic window. The importance of the primary lesion as a determinant of survival. (1982) (9)
What is the role of intraoperative manometry? (1980) (9)
Trial of vindesine, etoposide, and cisplatin in patients with previously treated, advanced-stage, non-small cell bronchogenic carcinoma. (1984) (9)
Postprandial acid reflux is reduced by delayed gastric emptying. (2003) (9)
Drug-induced esophageal injury (1990) (9)
En bloc oesophagectomy for cancer of the distal oesophagus, cardia and proximal stomach (1994) (8)
Gastroesophageal reflux. (1993) (8)
The Future: Endoscopic Antireflux Repair Via The Endo-Organ Approach (1995) (8)
Can clinical and endoscopic findings accurately predict early-stage adenocarcinoma? (2006) (8)
Surgical Options for the Treatment of Gastroesophageal Reflux Disease. (2017) (8)
Deliberate renal ischemia. A valuable and safe adjunct during operations upon the abdominal aorta. (1972) (8)
Therapy of noncardiac chest pain: is there a role for surgery? (1992) (8)
Physiology of the Antireflux Barrier and Diagnostic Tests of Foregut Function (1995) (7)
Reflux Disease Limited to the Dilated End-Stage Esophagus: The Pathologic Basis of NERD (2006) (7)
Endoscopic augmentation of the cardia with a biocompatible injectable polymer (Enteryx) in a porcine model (2002) (7)
Greenfield filter vs Mobin-Uddin umbrella. (1980) (7)
Quantification of the Duodenogastric Reflux in Gastroesophageal Reflux Disease (1988) (7)
A New Pathologic Assessment of Gastroesophageal Reflux Disease: The Squamo-Oxyntic Gap. (2016) (7)
Neuropeptide release from the isolated, perfused, lower esophageal sphincter region of the rabbit and the effect of vasoactive intestinal peptide on the sphincter. (1992) (7)
The slow motorized pull-through: An improved technique to evaluate the lower esophageal sphincter (1992) (7)
Esophageal pH exposure and epithelial cell differentiation. (2009) (7)
Small-cell carcinoma of the lung. (1978) (7)
Position of the distal esophageal sphincter and its relationship to reflux. (1975) (7)
Cost Benefit Aspects in the Management of Gastroesophageal Reflux Disease (1988) (6)
Esophageal Replacement With Colon Interposition (1997) (6)
Postoperative recurrence of lung cancer: detection by whole-body gallium scintigraphy. (1986) (6)
Intragastric pH pattern analysis in patients with duodenogastric reflux. (1990) (6)
Surgical therapy in Barrett's esophagus. (2001) (6)
Outcome of respiratory symptoms after surgical treatment of swallowing disorders (1995) (6)
Esophagectomy for benign disease: use of the colon. (1994) (6)
Modern Approach to Benign Esophageal Disease: Diagnosis and Surgical Therapy (1995) (6)
Preoperative diagnosis of lymph node metastasis: a dream? (2006) (6)
Cancer of the esophagus (1987) (6)
Manometry of individual segments of the distal esophageal sphincter. Its relation to functional incompetence. (1993) (6)
Biopsy of upper gastrointestinal tract lesions. Indications and clinical significance. (1995) (6)
Change, relationships, and accountability: Marks of a vibrant society (2007) (6)
Multiple transections of the thoracic aorta secondary to blunt trauma. (1973) (6)
Proceedings from an international conference on ablation therapy for Barrett's mucosa. Brittany, France, 31 August-2 September 1997. (1998) (6)
Clinical Significance of p 53 Mutations in Adenocarcinoma of the Esophagus and Cardia (2000) (6)
Patient response to marketing minimally invasive surgery for heartburn (1998) (6)
A new form of access for endo-organ surgery (1999) (5)
Collis-Belsey antireflux procedure. (1995) (5)
The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment. A surgeon's response. (1996) (5)
Laparoscopic Ultrasonic Epithelial Ablation of the Lower Esophagus after Nissen Fundoplication in a Porcine Model: Assessment of Tissue Damage and Healing Process (2001) (5)
Objective Documentation of the Link between Gastroesophageal Reflux Disease and Obesity: 59 (2007) (5)
Pre- and Postoperative Assessments in Gastroesophageal Reflux Disease (1994) (5)
Role of the Overall Length of the Distal Esophageal Sphincter in the Antireflux Mechanism (1988) (5)
Lung cancer: A combined modality approach to staging and therapy (1979) (5)
Bile reflux in Barrett's esophagus: the chicken or the egg? (1996) (5)
Drug-Induced Esophageal Injury: A Case Report of Percogesic (1989) (5)
Surgical approach to non-small cell lung cancer stage I and II. (1990) (5)
Management of adenocarcinoma arising in Barrett's esophagus. (1997) (5)
Esophageal Disease and Testing (2005) (5)
Barrett???s Esophagus: The Process of Intestinalization (2001) (5)
Evolving concepts of reflux: the ups and downs of the LES. (2002) (5)
Towards the Molecular Characterization of Disease: Comparison of Molecular and Histological Analysis of Esophageal Epithelia (2007) (4)
The “nutcracker esophagus” — A distinct motor disorder? (1990) (4)
Functional evaluation of the colonic interposition operation for benign esophageal stricture. (1971) (4)
Intra-abdominal pressure as a cause of gastroesophageal reflux: a study in man. (1978) (4)
Overview of Gastroesophageal Reflux Disease (2006) (4)
Severity of GERD and disease progression. (2021) (4)
Microvasive gastric stapler: the device, technique, and preclinical results. (2003) (4)
Regarding "Two-year results of intermittent electrical stimulation of the lower esophageal sphincter treatment of gastroesophageal reflux disease". (2015) (4)
A Study of the Interrelationship Between Esophageal Disease and Coronary Artery Disease as the Cause of Chest Pain (1988) (4)
Proceedings: Re-examination of the response of the lower oesophageal high pressure zone to abdominal compression. (1976) (4)
Histologic Definitions and Diagnosis of Epithelial Types (2006) (4)
Gastro-esophageal reflux disease confined to the sphincter. (2001) (4)
Adriamycin-radiotherapy interaction. (1977) (4)
SURGICAL TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE WITH EMPHASIS ON RESPIRATORY SYMPTOMS (1999) (4)
Risk factors for gastroesophageal reflux disease (2000) (4)
Twenty-four-hour lower esophageal pH monitoring and the lower esophageal sphincter. (1975) (4)
Esophageal Intraepithelial Eosinophils in Dysphagic Patients with Gastroesophageal Reflux Disease (2010) (3)
Therapeutic options for patients with alkaline gastro-esophageal reflux. (1994) (3)
Central control of esophageal peristalsis (1990) (3)
Ambulatory esophageal pH monitoring in patients with motility disorders (2004) (3)
Propensity score–matched comparison between open and minimal invasive hybrid esophagectomy for esophageal adenocarcinoma (2020) (3)
An Alkaline Stomach Is Common to Barrett’s Esophagus and Gastric Carcinoma (1993) (3)
Short answer in short segment Barrett's oesophagus. (1997) (3)
The 24-hour intra-esophageal pH Monitoring Test in the diagnosis of gastroesophageal reflux. (1982) (3)
Cervical Dysphagia is Associated with Gastric Hyperacidity (1993) (3)
Circadian esophageal motor function in diffuse esophageal spasm: Effect of long esophageal myotomy (1992) (3)
Surgery for carcinoma of the thoracic esophagus: Adams and Phemister in perspective. (1988) (3)
Gastroesophageal Reux in Achalasia When Is Reux Really Reux (1997) (3)
Outcome effect of adherence to operative principles of Nissen fundoplication by multiple surgeons. Discussion. Comment (1993) (3)
Cyclooxygenase-2 (COX-2) mediated anti-apoptosis may occur via Bcl-2 in the progression of Barrett's esophagus to adenocarcinoma. (2004) (3)
[Errors and dangers of laparoscopic anti-reflux surgery]. (1993) (3)
The University of Chicago contribution to the treatment of gastroesophageal reflux disease and its complications: a tribute to David B. Skinner 1935-2003. (2015) (3)
Manometry of the pharynx and upper esophageal sphincter using closely spaced transducers (1992) (3)
Surgical treatment of esophageal carcinoma. (1991) (3)
Staging lung cancer. (1980) (2)
Gastroesophageal reflux. (1976) (2)
Erratum to: Obesity and Gastroesophageal Reflux: Quantifying the Association Between Body Mass Index, Esophageal Acid Exposure, and Lower Esophageal Sphincter Status in a Large Series of Patients with Reflux Symptoms (2010) (2)
The Pathology of Reflux Disease at a Cellular Level: Part 2—Evolution of Cardiac Mucosa to Oxyntocardiac Mucosa and Intestinal Metaplasia (2006) (2)
Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinoma. (1978) (2)
Bile salt-induced mutation In vitro (1998) (2)
Gastroesophageal reflux in achalasia. When is reflux really reflux (1997) (2)
Surgical management of esophageal disorders (1991) (2)
Ineffective surveillance does not improve survival in patients with Barrett's who progress to adenocarcinoma. (2014) (2)
RETINOIC ACID RECEPTOR A(ALPHA) MESSENGER RNA EXPRESSION IS INCREASED AND RETINOIC ACID Y(GAMA)IS DECREASED IN BARRETTE'S INTESTINAL METAPLASIA, DYSPLASIA, ADENOCARCINOMA SEQUENCE (2001) (2)
Pathogenesis of esophagitis in patients with gastroesophageal reflux. (1980) (2)
Are the motility abnormalities of achalasia reversible? An experimental study (1995) (2)
Why another journal? (1997) (2)
Early experience with laparoscopic nissen fundoplication. (1995) (2)
25th Anniversary State-of-the-Art Expert Discussion With Tom R. DeMeester, MD, on GERD. (2015) (2)
Immunology and thoracic surgery. (1976) (2)
T2005 Dual Probe pH Monitoring: Improved Definition of Normal Proximal Acid Exposure (2008) (2)
Transient Lower Esophageal Sphincter Relaxations and Mechanical Incompetence of the Lower Esophageal Sphincter – Is There a Relationship? (2020) (2)
Magnetic LES Augmentation: The LINX Procedure (2015) (2)
Medical Therapy of Gastroesophageal Reflux Disease Assessed by Twenty-Four-Hour Esophageal pH Monitoring (1988) (2)
What are the relations between gastroesophageal reflux and pharyngoesophageal dysphagia (1989) (2)
The role of the lower esophageal sphincter and hiatal hernia in the pathogenesis of gastroesophageal reflux disease (1998) (2)
Vector volume analysis of the lower esophageal sphincter demonstrates the effect of treatment of achalasia (1995) (1)
A new standardized method for measurement of the lower esophageal sphincter (1998) (1)
Radiology of the Esophagus (2005) (1)
Magnetic Augmentation of the Lower Esophageal Sphincter: Changing the Treatment Paradigm in Patients with Gastroesophageal Reflux Disease (2012) (1)
Surgery for esophageal cancer: State of the art and future perspectives (2002) (1)
The Future of Esophageal Surgery (2012) (1)
997 Sonic Hedgehog Gene Expression in Barrett's Esophagus and Esophageal Adenocarcinoma (2008) (1)
The initial experience with percutaneous endoscopic gastrostomy (1999) (1)
New Histologic Definitions of Esophagus, Stomach, and Gastroesophageal Junction (2006) (1)
M1604 Relation of Goblet Cell Density and Early Esophageal Adenocarcinoma Within Long Segment's Barrett's Esophagus (2008) (1)
Current management of patients with esophageal motor abnormalities. (1996) (1)
Laparoscopic fundoplication in patients with Barrett's esophagus (1998) (1)
VP16-213 in combined modality treatment of small cell carcinoma of the lung. (1982) (1)
Integrated ambulatory foregut monitoring in patients with functional foregut disorders. (1992) (1)
Normal esophageal motor function: A manometric study of 136 healthy subjects (1992) (1)
Effect of Increased Intra-abdominal Pressure on the Esophagogastric Junction (2022) (1)
The Past, Present, and Future of Columnar-Lined (Barrett) Esophagus (2006) (1)
A method of valvuloplastic esophagogastrostomy to prevent reflux after proximal gastrectomy: invited commentary. (1978) (1)
A new intraluminal anti gastroesophageal reflux procedure (1996) (1)
Invited letter concerning: peptic esophageal stricture. (1991) (1)
Esophagoscopy for surgeons (2000) (1)
How does intra-abdominal pressure contribute to the continence of the cardia? (1989) (1)
Role of LES Augmentation for Early Progressive Disease in GERD and Fundoplication for End-Stage Disease in GERD (2016) (1)
Upregulation of ornithine decarboxylase MRNA expression in Barrett's esophagus (2000) (1)
Effect of nissen fundoplication on esophageal body function (1991) (1)
Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine. (1978) (1)
Management of high grade dysplasia in Barrett's esophagus - Results of a panel discussion at the IGSC Congress 1994. (1995) (1)
Pathology of Reflux Disease at a Cellular Level: Part 3—Intestinal (Barrett) Metaplasia to Carcinoma (2006) (1)
Ambulatory pH Monitoring (2005) (1)
Clinical manifestations, diagnosis, and treatment of hiatal hernia. (1986) (1)
Secondary esophageal peristalisis: Evidence for a neuromuscular afferent pathway (1998) (1)
Evaluation of duodenogastric reflux in patients with gastric symptoms utilizing a fiberoptic sensor for bilirubin (1995) (1)
Recurrence of intramucosal esophageal adenocarcinoma arising in a former esophagostomy site: a unique case report. (2009) (1)
W1851 Magnetic Sphincter Augmentation Is Safe and Effective for the Long-Term Treatment of Gastroesophageal Reflux Disease (GERD) (2009) (1)
Plasma DNA: A Molecular Marker of Surgical Insult and Postoperative Recovery in Esophageal Cancer (2008) (1)
Hyperplastic cholecystoses. (1972) (1)
600 Adenocarcinoma of the Esophagus in the Young (2010) (1)
Lack of efficacy of vinblastine and cisplatin in patients with progressive small cell carcinoma of the lung. (1983) (1)
Rationale for Treatment of Reflux Disease and Barrett Esophagus (2006) (0)
Thymidylate synthase polymorphism in the development of Barrett's associated adenocarcinoma. (2004) (0)
Mutationen im Osophagus verursacht durch gastro-osophagealen Reflux Reflux induced esophageal mutations (2001) (0)
Insights Gained From the Symptomatic Evaluation of Classification of Esophageal Motility Disorders: A Review of 4215 Patients: 40 (2009) (0)
Acknowledgement of Reviewers 2011 (2012) (0)
Research Strategies for Preventing Reflux-Induced Adenocarcinoma (2006) (0)
Normal Anatomy; Present Definition of the Gastroesophageal Junction (2006) (0)
Who controls medical education? Report of the 1975 Association for Academic Surgeons Committee on Issues. (1977) (0)
Safe insertion of the bougie for esophageal surgery. (1997) (0)
Royal academy of medicine Section of medicine/irish thoracic society (1984) (0)
The mechanical effect of the angelchik antireflux prosthesis on the lower esophageal sphincter (1986) (0)
Postoperative Recurrence of Lung Cancer: Detection by (1986) (0)
P59. Towards the molecular characterization of disease: Comparison of molecular and histological analysis of esophageal epithelia (2006) (0)
Summary of the Panel on “Cost Benefit of Diagnostic Maneuvers in the Esophagus for Benign Disease” (1988) (0)
Thymidylate synthase polymorphisms and its mRNA expression levels as independent chemo-predictive markers in esophageal adenocarcinoma patients receiving 5-fluorouracil chemotherapy. (2006) (0)
History of the International Society for Diseases of the Esophagus. (2012) (0)
SurgicalTherapyinBarrett's Esophagus (1990) (0)
Realization of the esophageal cancer model in mice (2003) (0)
566 An Improved Method of Assessing Esophageal Emptying Using the Timed Barium Study Following Surgical Myotomy for Achalasia (2008) (0)
Patient Preparation and Passage of the Manometry Catheter (2003) (0)
Pathology of Reflux Disease at a Cellular Level: Part 1—Damage to Squamous Epithelium and Transformation into Cardiac Mucosa (2006) (0)
Alkaline gastroesophageal reflux—Quantitation and clinical implications (1993) (0)
W1514 Mucosal Stripping Vagal Sparing Esophagectomy for END Stage Achalasia (2009) (0)
Circadian esophageal motor function in achalasia (1992) (0)
Surgical management of Barrett's esophagus. (1995) (0)
982 Spontaneous Reflux During Videoesophagram: Its Clinical Significance and Correlation With pH Monitoring (2010) (0)
Mo1489 Resolution of Anemia Following Repair of Giant Paraesophageal Hernias (2012) (0)
Prognostic markers for response and overall survival in patients with esophageal adenocarcinoma treated with neoadjuvant therapy. (2010) (0)
Re: High-Resolution Manometry and Lower Esophageal Sphincter Length (2010) (0)
Gastrointestinal hormone abnormalities in duodenogastric reflux disease and the response to pancreatico-biliary diversion (1992) (0)
Symptomatic outcome after heller myotomy and dor versus Toupet fundoplication for achalasia (2003) (0)
Ambulatory Motility Manometry (2003) (0)
The Value of a Scoring System in Gastroesophageal Reflux Disease: Does It Predict the Response to Surgical Treatment? (1993) (0)
593 Intraoperative Assessment of Perfusion in Gastric Grafts for Reconstruction After Esophagectomy: Predicting Anastomotic Complications (2010) (0)
SURGICAL GRAND ROUNDS 8:00a.m., Room 5AB100 Spring 2010 (2010) (0)
W1512 Diet Restriction Reduces Day-to-Day Variability in Acid Reflux Patterns Using the BRAVO pH Monitoring System (2009) (0)
Invited commentary (2005) (0)
The Abnormal Esophagus (2003) (0)
Invited commentary (2005) (0)
Polymorphisms in epidermal growth factor (EGF) and proteinase activated receptor 1 (PAR-1) associated with tumor recurrence in localized adenocarcinoma (EA) of the esophagus treated with surgery alone. (2009) (0)
Summary of the Panel on “Surgical Treatment of Reflux Disease Today” (1988) (0)
Effect of enprostil on lower esophageal sphincter pressure in patients with gastroesophageal reflux disease (1987) (0)
Esophageal Anatomy and Function (2010) (0)
delicate for the precise diagnosis of GERD in the literature ( (2018) (0)
The internet—A useful communication tool but no replacement for the doctor-patient relationship (2001) (0)
Ramp Bolus Pressure: A Determinant for Tailoring the Degree of the Fundoplication (2011) (0)
Experimental and ClinicalResults withProximal End-to-End Duodenojejunostomy forPathologic Duodenogastric Reflux (1987) (0)
‘Vigorous’ achalasia is not simply an early manifestation of the disease (2001) (0)
Ultrasonic intraluminal ablation of esophageal mucosa: A new technique for the eradication of Barrett's epithelium (1996) (0)
The Impact of Barrettʼs Surveillance on Esophageal Preservation, Tumor Stage, and Survival with Esophageal Adenocarcinoma: 44 (2011) (0)
T1721 The Value of Endoscopic Ultrasound to Distinguish the Number of Lymph Node Metastases in Patients with Esophageal Adenocarcinoma (2008) (0)
Fiberoptic sensor for bilirubin (1995) (0)
Pathology of Reflux Disease at an Anatomic Level (2006) (0)
Molecular signature of esophageal adenocarcinoma derived from microarray analysis of paraffin-embedded specimens predicts systemic recurrence following resection (2007) (0)
Quantitation of esophageal motor abnormalities with ambulatory 24-hour esophageal manometry (1992) (0)
Use of colon as an oesophageal replacement (1994) (0)
Effect of different bile diversion procedures on gastric acid production and intragastric pH (1991) (0)
Symptoms and motility findings in gastroesophageal reflux disease (1992) (0)
W1513 Stapled Pyloroplasty: A Fast and Safe Technique (2009) (0)
Technical aspects of ambulatory esophageal manometry (1992) (0)
Invited commentary (2005) (0)
Lower esophageal sphincter residual pressure is related to dysphagia or recurrent reflux after nissen fundoplication (2000) (0)
Fetal Development of the Esophagus and Stomach (2006) (0)
T1566 Comparison of the Conventional Manometry and High Resolution Manometry in the Assessment of the Resting Characteristics of the Lower Esophageal Sphincter: the Enemy of Good Is Better (2009) (0)
Lung cancer: An immunologic viewpoint and the prospects for immunotherapy. (1976) (0)
Irish society of Gastroenterology (1991) (0)
The contribution of the sling fibers to lower esophageal sphincter asymmetry (1994) (0)
The intrathoracic stomach. (1998) (0)
Original scientific articleReply (2006) (0)
Invited commentary (2005) (0)
A study of 100 patients with hypertensive lower esophageal sphincter (2000) (0)
W1757 Interstitial Cells of Cajal in Achalasia (2009) (0)
The Role of the Lower Esophageal Sphincter’s Position to Competency of the Cardia: An Experimental Study in Cats (1988) (0)
The video-esophagogram: Defining normality to evaluate patients with esophageal disease (2003) (0)
Concomitant Duodenogastric and Gastroesophageal Reflux: The Role of Twenty-Four-Hour Gastric pH Monitoring (1988) (0)
The Effect of Gastric Distension by a Fatty Meal on the Exposure of the Lower Esophageal Sphincter to Acid Gastric Juice in Normal Subjects: 26 (2010) (0)
Filling an umet need (1997) (0)
Challenges in the Understanding and Application of Antireflux Surgery for GERD (2021) (0)
Invited letter concerning: Surgery and the management of peripheral T3 tumors of the lung: Reply to the Editor (1992) (0)
M1850 Bile Reflux Induces Higher COX-2 Expression Than Mixed Acid and Bile Reflux in a Rat Model of Esophagitis (2008) (0)
A new focus on pharyngoesophageal interaction in achalasia (1994) (0)
Summary of the Panel on “Useful Tests in the Assessment of Gastroesophageal Reflux” (1988) (0)
Ambulatory measurement of gastric emptying: Introduction of an intragastric gamma detecting probe (1995) (0)
Color Atlas of Emergency Trauma: Forewords (2003) (0)
Thymidylate synthase polymorphism in the development of Barrett's associated adenocarcinoma (2004) (0)
Comment: Delayed cervical esophagogastrostomy: a surgical alternative for patients with ischemia of the gastric conduit at time of esophagectomy. (2014) (0)
Invagination device within the esophagus. (1991) (0)
Upregulation of c-myb mRNA expression in barrett's esophagus (2000) (0)
The Impact of Delayed Gastric Emptying on Outcome of Nissen Fundoplication in GERD Patients (2011) (0)
Glutathione S-transferase P1 mRNA expression is down-regulated in patients with Barrett's esophagus and esophageal adenocarcinoma (2001) (0)
Clinical and manometric features of the hypoplastic esophagus (2001) (0)
The myth of dysphagia after antireflux surgery: Analysis of swallowing difficulty in patients with GERD (2000) (0)
Defective lower esophageal sphincter and gastroesophageal reflux: Cause or effect? (1994) (0)
Making sense of ambulatory esophageal motility (1992) (0)
M1574 Esophagectomy for Cancer in Octogenarians (2009) (0)
Paraesophageal Hiatal Hernia (2011) (0)
Anti-apoptosis and pro-apoptosis gene expressions in Barrett's epithelial tumorigenesis (2005) (0)
Exposure of the mucosa at the gastroesophageal junction to a PH of 2–4 may induce intestinal metaplasia (2004) (0)
SCL2 CARCINOMA OF THE ESOPHAGUS : JAPANESE INFLUENCE ON THE AMERICAN SURGEON (2000) (0)
The mutagenic potential of duodeno-gastroesophageal reflux (2000) (0)
Intraepithelial Eosinophil Infiltration in Patients with GERD: Correlation with Dysphagia (2008) (0)
Device for a ösophagische invagination (1991) (0)
Hernias and Volvulus (2010) (0)
The significance of plateau pressure in a hiatal hernia noted on esophageal manometry (2001) (0)
Original scientific articleInvited commentary (2001) (0)
Invited commentary (2005) (0)
Manometric Placement of BRAVO Capsule and Its Impact on Day to Day Discrepancy in Measurement of Esophageal Acid Exposure: 23 (2008) (0)
Plasma DNA: A molecular marker for the pattern of dissemination of esophageal cancer (2007) (0)
Severe ineffective esophageal motility: results of antireflux surgery (2000) (0)
Tu1772 The Influence of Postoperative Complications on Recurrence and Long-Term Survival After Esophagectomy for Esophageal Cancer (2012) (0)
Department of Surgery, Keck School of Medicine, University of Southern California (2004) (0)
Perspectives and Lessons Learned on the Development and Collaboration in Foregut Disease (2021) (0)
Thank you to Annals of Surgical Oncology reviewers (2006) (0)
Su1523 The Status of the Lower Esophageal Sphincter at Rest and the Degree of Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (2012) (0)
Twenty-four hour pH score is still useful after 45 years. (2019) (0)
Is the Number of Lymph Nodes Removed and the Type of Resection Associated With Postoperative Complications After Esophagectomy for Esophageal Cancer (2011) (0)
M1974 Cdx-2 and Sonic Hedgehog Gene Expression in the Proximal, Middle, and Distal Regions of Columnar Mucosa in Long Segment Barrett's Esophagus (2008) (0)
Association Between Goblet Cell Density and Intraluminal pH in Patients with Long Segment Barrettʼs Esophagus: 35 (2009) (0)
Adenosquamous Carcinoma, Esophagus, Rat (1997) (0)
The utility of preoperative endoscopic ultrasound staging of esophageal cancer in a surgical practice (2000) (0)
Diet Restriction Reduces Day-to-Day Variability in Acid Reflux Patterns Using the BRAVO pH Monitoring System: 82 (2008) (0)
82 Biomechanical Augmentation of the Lower Esophageal Sphincter (LES) Using a Magnetic Sphincter Device - Initial Results of a Pilot Trial for the Treatment of GERD (2008) (0)
Predictive value of preoperative plasma DNA level for early recurrence after resection in esophageal adenocarcinoma (2008) (0)
Is a good clinical result satisfactory if there is no equivalent manometric improvement (1991) (0)
Esophagus Analysis of Predictors and Clinical Implications (1999) (0)
Proximal esophageal acid exposure is associated with hypertensive contractions in the distal esophagus (2003) (0)
Ultrastructural characteristics of regenerating squamous islands in barrett's epithelium (2000) (0)
Symptoms and Functional Foregut Abnormalities in Patients with Complications of Gastroesophageal Reflux Disease (1993) (0)
The Normal Esophagus (2003) (0)
792 Loss of Alkalization in Proximal Esophagus: A New Diagnostic Paradigm for Patients With Laryngopharyngeal Reflux (2010) (0)
ORIGINAL ARTICLES—ALIMENTARY TRACT Bravo Catheter-Free pH Monitoring: Normal Values, Concordance, Optimal Diagnostic Thresholds, and Accuracy (2008) (0)
289 Long-Term Follow-up After Anti-Reflux Surgery in Patients With Barrett's Esophagus (2010) (0)
Adenocarcinoma of the Esophagus : Risk Factors and Prevention (2017) (0)
ANTIREFLUX SURGERY PROMOTES OR INDUCES HEALING OR REGRESSION OF THE METAPLASTIC EPITHELIUM SUCH THAT THE CANCER RISK EPITHELIUM (2002) (0)
Diagnosis of Gastroesophageal Reflux Disease, Barrett Esophagus, and Dysplasia (2006) (0)
M1837 Schatzki's Ring and GERD: Association Between Esophageal Acid Exposure and Imaging Findings (2009) (0)
T2006 Measurement of Pharyngeal pH: A New Technology and Normal Values (2008) (0)
Simultaneous manometry, fluorography and impedance studies of the pharynx-new inslights in bolus transport (2001) (0)
Diagnostic Procedures for Esophageal Disease (1986) (0)
Is the measurement of LES always parallel to the functional results of an antireflux procedure (1989) (0)
Definition of Gastroesophageal Reflux Disease and Barrett Esophagus (2006) (0)
Ambulatory pH and Bilitec Monitoring (2003) (0)
[Endoscopic intraluminal valvuloplasty--a therapy of the future for gastroesophageal reflux]. (1998) (0)
Special problems in minimally invasive surgery of the foregut. Part III: Special problems with antireflux procedures (2001) (0)
Clinical Use of Ambulatory 24-H Esophageal Motility Monitoring in the Evaluation of Patients with Primary Esophageal Motor Disorders (1993) (0)
Continuing medical education program: Controversies in the current therapy of carcinoma of the esophagus; depression, anxiety, and asthenia in advanced illness (2002) (0)
Yield pressure of the pyloric and cardiac sphincter during gastric distension in the baboon (1998) (0)
Treatment Strategies for Preventing Reflux-Induced Adenocarcinoma (2006) (0)
Schatzki's rings are strongly associated with hiatal hernia and gastroesophageal reflux disease (2000) (0)
The Gene Expression Profile of Cardiac Intestinal Metaplasia Is Similar to Barrettʼs Esophagus, Not Gastric Intestinal Metaplasia: 60 (2005) (0)
Dispositif pour l'invagination d'un oesophage (1991) (0)
Barrett's mucosal thickness: A consideration during ablation (2001) (0)
IX World congress of the ISDE. What's new in pathophysiology, diagnosis and treatment (2006) (0)
DNA methylation patterns predict clinical outcome in esophageal adenocarcinoma (2001) (0)
Proceedings from an international conference on ablation therapy for Barrett's mucosa: Brittany, France, 31 August - 2 September 1997. (2017) (0)
Comment: Delayed Cervical Esophagogastrostomy: A Surgical Alternative for Patients With Ischemia of the Gastric Conduit at Time of Esophagectomy (2014) (0)
Occupational indications for early surgical repair of hiatus hernia. (1973) (0)
Patient selection for laparoscopic nissen fundoplication (1995) (0)
THORACIC AND CARDIOVASCULAR SURGERY OFFICIAL PUBLICATION OF The American Association for Thoracic Surgery and The Western Thoracic Surgical Association (1995) (0)
Surgical treatment of esophageal disorders (1993) (0)
W1073 Long-Term, Safe and Effective Treatment of Gastroesophageal Reflux Disease Using a Sphincter Augmentation Device (2010) (0)
T1570 Endoscopic Therapy for Benign and Malignant Esophageal Lesions (2009) (0)
Subject Index, Vol. 8, Supplement 1, 1990 (1990) (0)
563 A New Biomechanical Device to Augment Lower Esophageal Sphincter (LES) Continence in Patients with Gastroesophageal Reflux Disease (GERD). Initial Results of a Pilot Clinical Trial (2008) (0)
Barrett's esophagus in women, a manifestation of severe gastroesophageal reflux disease (2001) (0)
Progressive mucosal injury in patients with gastroesophageal reflux disease and increasing peripheral blood eosinophil counts. (2010) (0)
Staging of Patients with Bronchogenic Carcinoma (1980) (0)
How does the length of the abdominal esophagus contribute to the continence of the cardia (1989) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Thomas R. Dr Demeester?

Thomas R. Dr Demeester is affiliated with the following schools:

Thomas R. Dr Demeester's Academic­Influence.com Rankings

Why Is Thomas R. Dr Demeester Influential?

Thomas R. Dr Demeester's Published Works

Published Works

What Schools Are Affiliated With Thomas R. Dr Demeester?

Thomas R. Dr Demeester's AcademicInfluence.com Rankings